+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection

Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection

Chest 121(1): 48-54

Background: Iron deficiency (ID) is common in patients with cystic fibrosis (CF) and may be related to GI factors and chronic inflammation. Pseudomonas aeruginosa (PA) infection is predominantly responsible for chronic lung suppuration in patients with CF, but its survival is critically dependent on the availability of extracellular iron, which it obtains via highly efficient mechanisms. Objective: To determine whether ID in CF patients is directly related to the severity of suppurative lung disease. Design: We determined the iron status of 30 randomly selected adult CF patients (13 women) and assessed the relationship to lung disease severity and GI factors by determining their daily sputum volume, FEV1 percent predicted, C-reactive protein (CRP) level, erythrocyte sedimentation rate, and degree of pancreatic supplementation. Additionally, we measured the sputum concentrations of iron and ferritin in a randomly selected subgroup of 13 of the 30 subjects. Setting: Adult CF Service in a tertiary-care center. Results: Seventy-four percent of subjects experienced ID (ie, serum iron levels ltoreq12 mumol/L and/or transferrin saturation levels ltoreq16%). There was no relationship found with the degree of pancreatic supplementation. The daily sputum volume was strongly associated with low serum iron levels, transferrin saturation, ferritin/CRP ratio, and FEV1 percent predicted (p<0.05). Serum iron levels and transferrin saturation were negatively related to CRP (r=-0.8 and r=-0.7, respectively; p<0.01) and erythrocyte sedimentation rate (r=-0.5 and r=-0.4, respectively; p<0.05). FEV1 percent predicted was positively related to serum iron level (r=0.5; p<0.01), transferrin saturation (r=0.4; p<0.05), and ferritin/CRP ratio (r=0.7; p<0.05). Sputum iron concentration (median, 63 mumol/L; range, 17 to 134 mumol/L) and ferritin concentration (median, 5,038 mug/L; range, 894 to 6,982 mug/L) exceeded plasma levels and negatively correlated with FEV1 percent predicted (r=-0.6 and r=-0.5, respectively, pltoreq0.05). Conclusion: In our CF patients, ID was directly related to the increased severity of suppurative lung disease but not to the degree of pancreatic insufficiency. Iron loss into the airway may contribute to ID and may facilitate PA infection.

(PDF emailed within 1 workday: $29.90)

Accession: 010885158

Download citation: RISBibTeXText

PMID: 11796431

Related references

Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influence of local steroid treatment. Acta Paediatrica Scandinavica 72(2): 283-287, 1983

Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis. Pediatric Pulmonology 42(12): 1193-1197, 2007

Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease. Pediatric Pulmonology 46(5): 497-504, 2016

Chronic lung infection with pseudomonas aeruginosa in cystic fibrosis. Current Opinion in Infectious Diseases 4(2): 140-144, 1991

IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Apmis. Supplementum 66: 1-41, 1996

The glycosylation of airway mucins in cystic fibrosis and its relationship with lung infection by Pseudomonas aeruginosa. Advances in Experimental Medicine and Biology 535: 17-32, 2004

Animal models of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Drug Discovery Today: Disease Models 4(3): 99-104, 2007

IgG avidity to Pseudomonas aeruginosa over the course of chronic lung biofilm infection in cystic fibrosis. Journal of Cystic Fibrosis, 2017

Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs. Infection and Immunity 81(8): 2697-2704, 2013

Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis. Plos One 9(10): E109891-E109891, 2015

A model for chronic mucoid pseudomonas aeruginosa lung infection in mice with cystic fibrosis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 37: 27, 1997

Metabolic network analysis of Pseudomonas aeruginosa during chronic cystic fibrosis lung infection. Journal of Bacteriology 192(20): 5534-5548, 2010

Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infection and Immunity 73(4): 2504-2514, 2005

Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection. American Journal of Physiology. Lung Cellular and Molecular Physiology 286(4): L717-L726, 2003

Serum antibodies to Pseudomonas aeruginosa outer-membrane proteins and iron-regulated membrane proteins at different stages of chronic cystic fibrosis lung infection. Journal of Medical Microbiology 34(4): 203-212, 1991